Teresa Van Woy in San Pablo, California

Home California San Pablo

Teresa Van Woy has Podiatry as her primary medical specialty. Their primary office is: 2089 Vale Rd in San Pablo, California. They attended California School Of Podiatric Medicine and graduated in 1996 (around 28 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Teresa M Van Woy Office Phone and Directions

Teresa Van Woy
2089 Vale Rd
San Pablo, California 94806
510-232-0892

Patient Ratings
Please rate your experience with Teresa Van Woy below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 510-232-0892

Enter a starting address:

Healthcare Info for Teresa Van Woy

Medical School: California School Of Podiatric Medicine
Graduation Year: 1996
The Primary Medical Specialty for Teresa Van Woy is listed as: Podiatry
Approximate Years of Experience: 28
PAC (PECOS ID)#: 7214053776
NPI #: 1124182316
NPI Created On: 12/21/2006
NPI Last Updated Listed as: 09/29/2015
Primary Taxonomy Code: 213EP1101X
License Number:
E4247
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Removal of 2 to 4 thickened skin growths
Removal of tissue from 6 or more finger or toe nails
New patient office or other outpatient visit, typically 30 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 842976307

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Pharma Product

Name of Drug #1: COLLAGENASE SANTYL

Open Associated Drug #1: 50484-010-30